Skip to content
10-K

Annual Report

BIOCRYST PHARMACEUTICALS INC BCRX

0001628280-26-012240

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 20, 2026 250.8M sh
Shares Diluted FY 2025 · Dec 31, 2025 218.58M sh
Shares Diluted FY 2025 · Dec 31, 2024 206.7M sh
Shares Diluted FY 2025 · Dec 31, 2023 192.2M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 $347.37M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$52.02M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$95.14M
Long Term Debt FY 2025 · Dec 31, 2025 $0
Long Term Debt FY 2025 · Dec 31, 2024 $314.87M
Short Term Investments FY 2025 · Dec 31, 2025 $185.01M
Short Term Investments FY 2025 · Dec 31, 2024 $216.14M
Cash And Equivalents FY 2025 · Dec 31, 2025 $89.74M
Cash And Equivalents FY 2025 · Dec 31, 2024 $104.71M
Cash And Equivalents FY 2025 · Dec 31, 2023 $110.64M
Stockholders Equity FY 2025 · Dec 31, 2025 −$119.15M
Stockholders Equity FY 2025 · Dec 31, 2024 −$475.93M
Stockholders Equity FY 2025 · Dec 31, 2023 −$455.53M
Stockholders Equity FY 2025 · Dec 31, 2022 −$294.6M
Current Liabilities FY 2025 · Dec 31, 2025 $196.07M
Current Liabilities FY 2025 · Dec 31, 2024 $160.38M
Total Liabilities FY 2025 · Dec 31, 2025 $633.31M
Total Liabilities FY 2025 · Dec 31, 2024 $966.35M
Current Assets FY 2025 · Dec 31, 2025 $404.35M
Current Assets FY 2025 · Dec 31, 2024 $421.97M
Total Assets FY 2025 · Dec 31, 2025 $514.16M
Total Assets FY 2025 · Dec 31, 2024 $490.42M
Eps Diluted FY 2025 · Dec 31, 2025 $1.21
Eps Diluted FY 2025 · Dec 31, 2024 −$0.43
Eps Diluted FY 2025 · Dec 31, 2023 −$1.18
Eps Basic FY 2025 · Dec 31, 2025 $1.26
Eps Basic FY 2025 · Dec 31, 2024 −$0.43
Eps Basic FY 2025 · Dec 31, 2023 −$1.18
Sga Expense FY 2025 · Dec 31, 2025 $348.65M
Sga Expense restated FY 2025 · Dec 31, 2024 $266.35M
Sga Expense restated FY 2025 · Dec 31, 2023 $214.07M
Rd Expense FY 2025 · Dec 31, 2025 $166.13M
Rd Expense FY 2025 · Dec 31, 2024 $174.64M
Rd Expense FY 2025 · Dec 31, 2023 $216.57M
Net Income FY 2025 · Dec 31, 2025 $263.86M
Net Income FY 2025 · Dec 31, 2024 −$88.88M
Net Income FY 2025 · Dec 31, 2023 −$226.54M
Operating Income FY 2025 · Dec 31, 2025 $340.99M
Operating Income FY 2025 · Dec 31, 2024 −$2.54M
Operating Income FY 2025 · Dec 31, 2023 −$103.71M
Cost Of Revenue FY 2025 · Dec 31, 2025 $19.08M
Cost Of Revenue FY 2025 · Dec 31, 2024 $12.27M
Cost Of Revenue FY 2025 · Dec 31, 2023 $4.48M